940-7 |
Bombay Ag |
PrThr |
RBC^BPU |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Bombay Ag [Presence] on Red Blood Cells from Blood product unit |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
940-7 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Bombay Ag RBC BPU Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.61 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
9400-3 |
Platinum |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Platinum [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
9400-3 |
|
|
|
|
Both |
|
|
|
0 |
Platinum Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
1.0i |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
94000-7 |
Chloride^1H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94000-7 |
|
|
|
|
Observation |
|
|
|
0 |
Chloride 1h p Vaso SerPl-sCnc |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Cl; Cl-; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
94001-5 |
Bicarbonate^1H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bicarbonate [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94001-5 |
|
|
|
|
Observation |
|
|
|
0 |
HCO3 1h p Vaso SerPl-sCnc |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; BIC; bicar; Bicarb; CHEMISTRY.CHALLENGE TESTING; HCO3; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SBC; SBIC; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
94002-3 |
Anion Gap 3^1H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Anion gap 3 in Serum or Plasma --1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94002-3 |
|
|
|
|
Observation |
|
|
|
0 |
Anion Gap3 1h p Vaso SerPl-sCnc |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Ag; AnGAP; Anion Gap3; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; III; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
94003-1 |
Urea nitrogen^1H post dose vasopressin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
94003-1 |
|
|
|
|
Observation |
|
|
|
0 |
BUN 1h p Vaso SerPl-mCnc |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Blood urea nitrogen; BUN; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; N; N2; Nit; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
94004-9 |
Osmolality^1H post dose vasopressin |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
94004-9 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality 1h p Vaso SerPl |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
94005-6 |
Osmolality^1H post dose vasopressin |
Osmol |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Urine--1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
94005-6 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality 1h p Vaso Ur |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
94006-4 |
Sodium^2H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Sodium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94006-4 |
|
|
|
|
Observation |
|
|
|
0 |
Sodium 2h p Vaso SerPl-sCnc |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Na; Na+; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
94007-2 |
Potassium^2H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Potassium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94007-2 |
|
|
|
|
Observation |
|
|
|
0 |
Potassium 2h p Vaso SerPl-sCnc |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; k; K+; Level; p dose; Pl; Plasma; Plsm; Point in time; Potass; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
94008-0 |
Creatinine^2H post dose vasopressin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Creatinine [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
94008-0 |
|
|
|
|
Observation |
|
|
|
0 |
Creat 2h p Vaso SerPl-mCnc |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
94009-8 |
Chloride^2H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94009-8 |
|
|
|
|
Observation |
|
|
|
0 |
Chloride 2h p Vaso SerPl-sCnc |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Cl; Cl-; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
9401-1 |
Silicon |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Silicon [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
9401-1 |
|
|
|
|
Both |
|
|
|
0 |
Silicon Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; SI; Spec; To be specified in another part of the message; Unspecified |
2.7 |
1.0i |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
94010-6 |
Bicarbonate^2H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bicarbonate [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94010-6 |
|
|
|
|
Observation |
|
|
|
0 |
HCO3 2h p Vaso SerPl-sCnc |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; BIC; bicar; Bicarb; CHEMISTRY.CHALLENGE TESTING; HCO3; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SBC; SBIC; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
94011-4 |
Anion Gap 3^2H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Anion gap 3 in Serum or Plasma --2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
94011-4 |
|
|
|
|
Observation |
|
|
|
0 |
Anion Gap3 2h p Vaso SerPl-sCnc |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Ag; AnGAP; Anion Gap3; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; III; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
94012-2 |
Urea nitrogen^2H post dose vasopressin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
94012-2 |
|
|
|
|
Observation |
|
|
|
0 |
BUN 2h p Vaso SerPl-mCnc |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Blood urea nitrogen; BUN; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; N; N2; Nit; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
94013-0 |
Osmolality^2H post dose vasopressin |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
94013-0 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality 2h p Vaso SerPl |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
94014-8 |
Osmolality^2H post dose vasopressin |
Osmol |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Urine--2 hours post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
94014-8 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality 2h p Vaso Ur |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
94015-5 |
Mental health screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Mental health screening report |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94015-5 |
|
|
|
|
Both |
|
|
|
0 |
MH screen report |
|
|
|
|
|
Asympt; Asymptomatic; DOC.MISC; Document; Emotional stability; Finding; Findings; MH screen report; MISC; Point in time; Random; Scn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94016-3 |
Depression screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Depression screening report |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94016-3 |
|
|
|
|
Both |
|
|
|
0 |
Depression screen report |
|
|
|
|
|
Asympt; Asymptomatic; Depression screen report; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94017-1 |
Anxiety screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Anxiety screening report |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94017-1 |
|
|
|
|
Both |
|
|
|
0 |
Anxiety screen report |
|
|
|
|
|
Anxiety screen report; Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94018-9 |
ADHD screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
ADHD screening report |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94018-9 |
|
|
|
|
Both |
|
|
|
0 |
ADHD screen report |
|
|
|
|
|
ADHD screen report; Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94019-7 |
Bipolar screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Bipolar screening report |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94019-7 |
|
|
|
|
Both |
|
|
|
0 |
Bipolar screen report |
|
|
|
|
|
Asympt; Asymptomatic; Bipolar screen report; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9402-9 |
Acyl carnitine |
MCnc |
Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Acyl carnitine [Mass/volume] in Plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
9402-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated Acyl carnitine Plas-mCnc |
|
|
|
Y |
|
Carnitine.total; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.36 |
1.0i |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94020-5 |
Somatic symptom disorder screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Somatic symptom disorder screening report |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94020-5 |
|
|
|
|
Both |
|
|
|
0 |
SSD screen report |
|
|
|
|
|
Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; SSD screen report; Sx |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |